The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer

被引:1
作者
Zhang, Meilan [1 ]
Zheng, Zhaokuan [2 ]
Wang, Shouliang [3 ]
Liu, Ruihan [3 ]
Zhang, Mengli [3 ]
Guo, Zhiyun [1 ]
Wang, Hao [1 ]
Tan, Weige [3 ]
机构
[1] Guangzhou Med Univ, Affiliated Panyu Cent Hosp, Guangzhou 511400, Guangdong, Peoples R China
[2] Southern Med Univ, Affiliated Huadu Hosp, Peoples Hosp HuaduDist, Dept Orthoped, Guangzhou 510810, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 1, Dept Breast Surg, 151 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China
关键词
miRNAs; circRNAs; breast cancer; clinical values; PROMOTES TRASTUZUMAB-RESISTANCE; TAMOXIFEN RESISTANCE; MESSENGER-RNA; METASTASIS; BIOGENESIS; CHEMORESISTANCE; PROLIFERATION; ADRIAMYCIN; MECHANISMS; BIOMARKERS;
D O I
10.20517/cdr.2024.62
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are small non-coding RNAs comprising 19-24 nucleotides that indirectly control gene expression. In contrast to other non-coding RNAs (ncRNAs), circular RNAs (circRNAs) are defined by their covalently closed loops, forming covalent bonds between the 3' and 5' ends. circRNAs regulate gene expression by interacting with miRNAs at transcriptional or post-transcriptional levels. Accordingly, circRNAs and miRNAs control many biological events related to cancer, including cell proliferation, metabolism, cell cycle, and apoptosis. Both circRNAs and miRNAs are involved in the pathogenesis of diseases, such as breast cancer. This review focuses on the latest discoveries on dysregulated circRNAs and miRNAs related to breast cancer, highlighting their potential as biomarkers for clinical diagnosis, prognosis, and chemotherapy response.
引用
收藏
页数:13
相关论文
共 87 条
  • [1] Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
    Alunni-Fabbroni, Marianna
    Majunke, Leonie
    Trapp, Elisabeth K.
    Tzschaschel, Marie
    Mahner, Sven
    Fasching, Peter A.
    Fehm, Tanja
    Schneeweiss, Andreas
    Beck, Thomas
    Lorenz, Ralf
    Friedl, Thomas W. P.
    Janni, Wolfgang
    Rack, Brigitte
    Grp, S. U. C. C. E. S. S. Study
    [J]. BMC CANCER, 2018, 18
  • [2] circRNA Biogenesis Competes with Pre-mRNA Splicing
    Ashwal-Fluss, Reut
    Meyer, Markus
    Pamudurti, Nagarjuna Reddy
    Ivanov, Andranik
    Bartok, Osnat
    Hanan, Mor
    Evantal, Naveh
    Memczak, Sebastian
    Rajewsky, Nikolaus
    Kadener, Sebastian
    [J]. MOLECULAR CELL, 2014, 56 (01) : 55 - 66
  • [3] MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1
    Bao, Chang
    Chen, Jishun
    Chen, Danni
    Lu, Yunkun
    Lou, Weiyang
    Ding, Bisha
    Xu, Liang
    Fan, Weimin
    [J]. CELL DEATH & DISEASE, 2020, 11 (08)
  • [4] Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer
    Bao, Siqi
    Hu, Ting
    Liu, Jiaqi
    Su, Jianzhong
    Sun, Jie
    Ming, Yue
    Li, Jiaxin
    Wu, Nan
    Chen, Hongyan
    Zhou, Meng
    [J]. JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)
  • [5] The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
    Bielo, Luca Boscolo
    Trapani, Dario
    Nicolo, Eleonora
    Valenza, Carmine
    Guidi, Lorenzo
    Belli, Carmen
    Kotteas, Elias
    Marra, Antonio
    Prat, Aleix
    Fusco, Nicola
    Criscitiello, Carmen
    Burstein, Harold J.
    Curigliano, Giuseppe
    [J]. CANCER TREATMENT REVIEWS, 2024, 128
  • [6] Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray, Freddie
    Laversanne, Mathieu
    Sung, Hyuna
    Ferlay, Jacques
    Siegel, Rebecca L.
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) : 229 - 263
  • [7] miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response
    Cataldo, Alessandra
    Cheung, Douglas G.
    Balsari, Andrea
    Tagliabue, Elda
    Coppola, Vincenzo
    Iorio, Marilena V.
    Palmieri, Dario
    Croce, Carlo M.
    [J]. ONCOTARGET, 2016, 7 (01) : 786 - 797
  • [8] CircRNA_0044556 diminishes the sensitivity of triple-negative breast cancer cells to adriamycin by sponging miR-145 and regulating NRAS
    Chen, Jingjing
    Shi, Peng
    Zhang, Jinghua
    Li, Yufeng
    Ma, Jie
    Zhang, Yudong
    Liu, Hong
    [J]. MOLECULAR MEDICINE REPORTS, 2022, 25 (02)
  • [9] The expanding regulatory mechanisms and cellular functions of circular RNAs
    Chen, Ling-Ling
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (08) : 475 - 490
  • [10] The biogenesis and emerging roles of circular RNAs
    Chen, Ling-Ling
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2016, 17 (04) : 205 - 211